Log In
Print
BCIQ
Print
Print this Print this
 

LJM716

  Manage Alerts
Collapse Summary General Information
Company Novartis AG
DescriptionHuman HuCAL antibody against HER3
Molecular Target Epidermal growth factor receptor 3 (EGFR3) (HER3) (ErbB3)
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today